322 related articles for article (PubMed ID: 17592905)
1. Augmentation of antidepressants with atypical antipsychotic medications for treatment-resistant major depressive disorder: a meta-analysis.
Papakostas GI; Shelton RC; Smith J; Fava M
J Clin Psychiatry; 2007 Jun; 68(6):826-31. PubMed ID: 17592905
[TBL] [Abstract][Full Text] [Related]
2. Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials.
Nelson JC; Papakostas GI
Am J Psychiatry; 2009 Sep; 166(9):980-91. PubMed ID: 19687129
[TBL] [Abstract][Full Text] [Related]
3. Atypical antipsychotics for psychosis in adolescents.
Kumar A; Datta SS; Wright SD; Furtado VA; Russell PS
Cochrane Database Syst Rev; 2013 Oct; (10):CD009582. PubMed ID: 24129841
[TBL] [Abstract][Full Text] [Related]
4. Adjunctive aripiprazole in major depressive disorder: analysis of efficacy and safety in patients with anxious and atypical features.
Trivedi MH; Thase ME; Fava M; Nelson CJ; Yang H; Qi Y; Tran QV; Pikalov A; Carlson BX; Marcus RN; Berman RM
J Clin Psychiatry; 2008 Dec; 69(12):1928-36. PubMed ID: 19192475
[TBL] [Abstract][Full Text] [Related]
5. Meta-analysis on the efficacy and tolerability of the augmentation of antidepressants with atypical antipsychotics in patients with major depressive disorder.
Wen XJ; Wang LM; Liu ZL; Huang A; Liu YY; Hu JY
Braz J Med Biol Res; 2014 Jul; 47(7):605-16. PubMed ID: 24919175
[TBL] [Abstract][Full Text] [Related]
6. Second-generation antipsychotics for major depressive disorder and dysthymia.
Komossa K; Depping AM; Gaudchau A; Kissling W; Leucht S
Cochrane Database Syst Rev; 2010 Dec; (12):CD008121. PubMed ID: 21154393
[TBL] [Abstract][Full Text] [Related]
7. Does the presence of an open-label antidepressant treatment period influence study outcome in clinical trials examining augmentation/combination strategies in treatment partial responders/nonresponders with major depressive disorder?
Iovieno N; Papakostas GI
J Clin Psychiatry; 2012 May; 73(5):676-83. PubMed ID: 22569112
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerability of Z-drug adjunction to antidepressant treatment for major depressive disorder: a systematic review and meta-analysis of randomized controlled trials.
Kishi T; Matsunaga S; Iwata N
Eur Arch Psychiatry Clin Neurosci; 2017 Mar; 267(2):149-161. PubMed ID: 27318835
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression: a systematic review and meta-analysis of randomised placebo-controlled trials.
McGirr A; Vöhringer PA; Ghaemi SN; Lam RW; Yatham LN
Lancet Psychiatry; 2016 Dec; 3(12):1138-1146. PubMed ID: 28100425
[TBL] [Abstract][Full Text] [Related]
10. Brexpiprazole for schizophrenia and as adjunct for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antipsychotic - what is the number needed to treat, number needed to harm and likelihood to be helped or harmed?
Citrome L
Int J Clin Pract; 2015 Sep; 69(9):978-97. PubMed ID: 26250067
[TBL] [Abstract][Full Text] [Related]
11. A systematic review of augmentation strategies for patients with major depressive disorder.
Fleurence R; Williamson R; Jing Y; Kim E; Tran QV; Pikalov AS; Thase ME
Psychopharmacol Bull; 2009; 42(3):57-90. PubMed ID: 19752841
[TBL] [Abstract][Full Text] [Related]
12. Adjunctive low-dose aripiprazole with standard-dose sertraline in treating fresh major depressive disorder: a randomized, double-blind, controlled study.
Lin CH; Lin SH; Jang FL
J Clin Psychopharmacol; 2011 Oct; 31(5):563-8. PubMed ID: 21869699
[TBL] [Abstract][Full Text] [Related]
13. Aripiprazole augmentation of antidepressants for the treatment of partially responding and nonresponding patients with major depressive disorder.
Simon JS; Nemeroff CB
J Clin Psychiatry; 2005 Oct; 66(10):1216-20. PubMed ID: 16259533
[TBL] [Abstract][Full Text] [Related]
14. Are antipsychotics or antidepressants needed for psychotic depression? A systematic review and meta-analysis of trials comparing antidepressant or antipsychotic monotherapy with combination treatment.
Farahani A; Correll CU
J Clin Psychiatry; 2012 Apr; 73(4):486-96. PubMed ID: 22579147
[TBL] [Abstract][Full Text] [Related]
15. Efficacy, quality of life, and acceptability outcomes of atypical antipsychotic augmentation treatment for treatment-resistant depression: protocol for a systematic review and network meta-analysis.
Liu Y; Zhou X; Qin B; Del Giovane C; Zhang Y; Xie P
Syst Rev; 2014 Nov; 3():133. PubMed ID: 25373601
[TBL] [Abstract][Full Text] [Related]
16. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis.
Cipriani A; Furukawa TA; Salanti G; Chaimani A; Atkinson LZ; Ogawa Y; Leucht S; Ruhe HG; Turner EH; Higgins JPT; Egger M; Takeshima N; Hayasaka Y; Imai H; Shinohara K; Tajika A; Ioannidis JPA; Geddes JR
Lancet; 2018 Apr; 391(10128):1357-1366. PubMed ID: 29477251
[TBL] [Abstract][Full Text] [Related]
17. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a second multicenter, randomized, double-blind, placebo-controlled study.
Marcus RN; McQuade RD; Carson WH; Hennicken D; Fava M; Simon JS; Trivedi MH; Thase ME; Berman RM
J Clin Psychopharmacol; 2008 Apr; 28(2):156-65. PubMed ID: 18344725
[TBL] [Abstract][Full Text] [Related]
18. Augmentation of standard antidepressants with atypical antipsychotic agents for treatment-resistant major depressive disorder.
Papakostas GI
Essent Psychopharmacol; 2005; 6(4):209-20. PubMed ID: 16041917
[TBL] [Abstract][Full Text] [Related]
19. The efficacy and safety of aripiprazole as adjunctive therapy in major depressive disorder: a multicenter, randomized, double-blind, placebo-controlled study.
Berman RM; Marcus RN; Swanink R; McQuade RD; Carson WH; Corey-Lisle PK; Khan A
J Clin Psychiatry; 2007 Jun; 68(6):843-53. PubMed ID: 17592907
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of adjunctive cariprazine in inadequate responders to antidepressants: a randomized, double-blind, placebo-controlled study in adult patients with major depressive disorder.
Durgam S; Earley W; Guo H; Li D; Németh G; Laszlovszky I; Fava M; Montgomery SA
J Clin Psychiatry; 2016 Mar; 77(3):371-8. PubMed ID: 27046309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]